Peter Kim

PhD in Biochemistry (Stanford University)

We aim to devise new strategies to enable vaccine creation, and to create vaccines for some important infectious diseases, including HIV-1, pandemic influenza, and Ebola. We are also working to develop a room-temperature stable vaccine that provides durable and broad protection against SARS-CoV-2, with affordable worldwide access. Our research is primarily focused on antibody-mediated immune responses. As such, we investigate antigen-antibody interactions using biochemical, biophysical, and structural biological methods. We also interrogate B cell responses to vaccine candidates using single-cell sequencing methods to understand the germline B cells that are stimulated and the resultant somatic hypermutation.